performed in-vivo experiments with GTML model
performed in-vivo experiments with GTML model. Our study re-establishes mTOR as a central target in glioma and traces the failure of existing drugs to incomplete/nondurable inhibition of mTORC1. eTOC blurb Fan et al. target mTORC1 activity in glioblastoma Abacavir (GBM) with RapaLink-1, which is usually comprised of rapamycin linked to an mTOR kinase inhibitor. RapaLink-1 … Read more